Plain-English translation of NCT05469659 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a medication called can protect your kidneys better than , a common diabetes drug. Both medications help control blood sugar, but this study specifically wants to know if reduces protein leaking into your urine—a sign of kidney damage. You'll take one of these two medications for one year while doctors monitor your kidney health and blood sugar.
Many people with type 2 diabetes develop kidney damage over time, even when their blood sugar is controlled. Researchers believe this medication might offer extra kidney protection beyond just lowering blood sugar, which could slow or prevent kidney disease from getting worse.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either or daily for 52 weeks. During this year, you'll visit the clinic for regular check-ups where doctors will test your urine, blood sugar, blood pressure, kidney function, and weight. You'll also have blood tests to check cholesterol and other health markers. The study will track how much protein is in your urine and how well your kidneys are working to compare the two medications.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Japan